GEXVal Inc.

Pioneering solutions to improve lives through innovative treatments for rare and incurable diseases.

General Information
Company Name
GEXVal Inc.
Founded Year
2018
Location (Offices)
+1
Founders / Decision Makers
Number of Employees
5
Industries
Health Care
Funding Stage
Series C
Social Media

GEXVal Inc. - Company Profile

GEXVal Inc. is an R&D-focused drug discovery company founded in 2018 with a mission to develop pioneering solutions for rare and incurable diseases. The company's dedication to providing innovative and cost-effective treatment options in the Health Care industry sets it apart. GEXVal's recent ¥450.00M Series C investment on 04 December 2023 saw participation from notable investors including Mitsubishi UFJ Capital, SMBC Venture Capital, Axil Capital, UTC 2019 BioVentureFund, and Oita Venture Capital. This latest investment underscores confidence in GEXVal's commitment to improving lives through groundbreaking treatments, further solidifying its position as an innovative leader in the field.

Taxonomy: R&D-focused, drug discovery, treatments, rare diseases, incurable diseases, quality of life, cost-effective treatments

Funding Rounds & Investors of GEXVal Inc. (3)

View All
Funding Stage Amount No. Investors Investors Date
Series C ¥450.00M 5 04 Dec 2023
Series B ¥700.00M 5 eBEST, Yokohama Capital +2 10 Sep 2021
Series A ¥410.00M - 17 Jul 2018

Latest News of GEXVal Inc.

View All

No recent news or press coverage available for GEXVal Inc..

Similar Companies to GEXVal Inc.

View All
Genecure - Similar company to GEXVal Inc.
Genecure Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998.
York Pharma - Similar company to GEXVal Inc.
York Pharma Committed to developing and delivering top-quality dermatological treatments that enhance patient care and support healthcare professionals.
Alebund Pharmaceuticals - Similar company to GEXVal Inc.
Alebund Pharmaceuticals Innovate renal Therapeutics and provide the best solutions to renal patients
D-Sight S.L. - Similar company to GEXVal Inc.
D-Sight S.L. Spin-off company from VHIR developing new innovative treatments for neurodegenerative diseases of the retina.